Thus, under hypercholesterolemia, the B2 bradykinin receptor gene is atherogenic, leads to increased vascular ROS, mediates a decrease in (e)NOS activity as evidenced by a reduced aortic nitrate content, and enhances aortic BH4 deficiency (Figure 8B). Here, BDKRB2 is linked to Hypercholesterolemia.